Compound Summary
enoxacin
Compound Information
enoxacin
Compound Name: | enoxacin |
Compound CID: | 3229 |
Synonyms: | enoxacin 74011-58-8 Penetrex Enoxacine Comprecin More... |
Iupac Name: | 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid |
InChI: | InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23) |
InChIKey: | IDYZIJYBMGIQMJ-UHFFFAOYSA-N |
Canonical Smiles: | CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O |
Isomeric Smiles: | CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O |
Molecular Weight: | 320.32 |
Molecular Formula: | C15H17FN4O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
enoxacin
Molecular Weight: | 320.32 |
Molecular Formula: | C15H17FN4O3 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 8 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 23 |
Complexity: | 521 |
Synonyms
enoxacin
| enoxacin | enoxacin |
|---|---|
enoxacin |
74011-58-8 |
Penetrex |
Enoxacine |
Comprecin |
1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid |
Bactidan |
Enoxacino |
Enoxacinum |
Flumark |
AT-2266 |
Enoxor |
Almitil |
CI-919 |
enofloxacin |
CI 919 |
Enoxacin (Penetrex) |
PD 107779 |
1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
PD-107779 |
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid |
NSC 629661 |
Enoxacin (hydrate) |
UNII-325OGW249P |
CHEBI:157175 |
CHEMBL826 |
1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8naphthyridine-3-carboxylic acid |
Enoram |
Enoxin |
325OGW249P |
MFCD00133308 |
NSC629661 |
1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)- |
NSC-629661 |
AT 2266;CI 919 |
Enoxacine French |
Enoxacinum Latin |
NCGC00016927-01 |
Enoxacino Spanish |
Enoksetin |
CAS-74011-58-8 |
DSSTox_CID_2984 |
1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)- |
DSSTox_RID_76818 |
DSSTox_GSID_22984 |
Enoxacin sesquihydrate;AT-2266 hydrate;CI-919 hydrate |
Enofloxacine |
Bactidron |
Enoxen |
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
1-ethyl-6-fluoro-4-oxo-7-piperazinylhydropyridino2,3-bpyridine-3-carboxylic acid |
Penetrex (TN) |
SMR000058233 |
CCRIS 5242 |
Enoxacin (USAN/INN) |
SR-01000000202 |
NSC 627409 |
AT 2266 |
BRN 3628995 |
PD107779 |
Enoxacin USAN:INN:BAN:JAN |
ENX |
Prestwick_708 |
Spectrum_001539 |
Prestwick0_000353 |
Prestwick1_000353 |
Prestwick2_000353 |
Prestwick3_000353 |
Spectrum2_001731 |
Spectrum3_001570 |
Spectrum4_000166 |
Spectrum5_001044 |
E0762 |
Epitope ID:119069 |
Oprea1_147866 |
SCHEMBL33963 |
BSPBio_000445 |
BSPBio_003080 |
Enoxacin, analytical standard |
KBioGR_000651 |
KBioSS_002019 |
MLS000069645 |
MLS006011976 |
BIDD:GT0191 |
DivK1c_000420 |
SPECTRUM1503215 |
SPBio_001802 |
SPBio_002366 |
BPBio1_000491 |
GTPL8882 |
DTXSID5022984 |
BCBcMAP01_000009 |
HMS501E22 |
KBio1_000420 |
KBio2_002019 |
KBio2_004587 |
KBio2_007155 |
KBio3_002580 |
NINDS_000420 |
HMS1569G07 |
HMS1922I17 |
HMS2090E10 |
HMS2092N20 |
HMS2233K20 |
HMS3372A12 |
HMS3655M08 |
HMS3715H13 |
Pharmakon1600-01503215 |
BCP22623 |
HY-B0268 |
Tox21_110688 |
BDBM50296358 |
CCG-39452 |
NSC758416 |
s1756 |
ZINC19594549 |
AKOS015838626 |
Tox21_110688_1 |
DB00467 |
KS-5190 |
MCULE-2632820619 |
NSC-758416 |
IDI1_000420 |
SMP1_000113 |
NCGC00016927-02 |
NCGC00016927-03 |
NCGC00016927-04 |
NCGC00016927-05 |
NCGC00016927-06 |
NCGC00016927-07 |
NCGC00016927-08 |
NCGC00016927-10 |
NCGC00016927-11 |
NCGC00023864-03 |
NCGC00023864-04 |
NCGC00178309-01 |
NCGC00178309-02 |
K259 |
NCI60_009618 |
ST044514 |
SBI-0051788.P002 |
AB0014125 |
DB-055829 |
FT-0630825 |
SW196857-3 |
C06979 |
D00310 |
J10280 |
1, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl |
AB00052328-09 |
AB00052328_10 |
AB00052328_11 |
011E588 |
A837996 |
Q1639616 |
SR-01000000202-2 |
SR-01000000202-3 |
BRD-K78113049-001-05-5 |
BRD-K78113049-001-07-1 |
BRD-K78113049-001-12-1 |
Z1551429746 |
84294-96-2 (.1.5H2O) |
1-ethyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid |
1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro1,8naphthyridine-3-carboxylic acid |
1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid |
Experimental Data
enoxacin
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 100.000000000000000 | ug/mL | Unclear | N2 | 33683565 | ||||||||
| Caenorhabditis elegans | 100.000000000000000 | ug/mL | 18.000000000000000 | S | N2 | 33683565 | Active | ||||||
| Caenorhabditis elegans | 100.000000000000000 | ug/mL | 18.000000000000000 | S | N2 | 29986212 | Active |
Experimental Data Visualization
enoxacin
Statistics Data
enoxacin
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 18.000000000000000 | 2 | 3 |
Statistics Data Visualization
enoxacin
